Pro Medicus Limited
Other OTCCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Sam Aaron Hupert
- Full Time Employees
- 132
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- Address
- 450 Swan Street Richmond VIC Australia 3121
- IPO Date
- Jan 8, 2021
- Website
- promed.com.au
- Similar Companies
- Business
- Pro Medicus Limited is an Australia-based healthcare informatics company specializing in the development and supply of proprietary medical imaging software and integrated IT solutions for hospitals, imaging centers, and healthcare groups globally. Its core products include advanced visualization software, enterprise imaging solutions, radiology workflow management systems, and cloud-based imaging services that enable seamless streaming and remote diagnostic capabilities. The company operates through its flagship Visage brand, which encompasses high-performance image viewer, workflow, and archive platforms, as well as expanding offerings into digital pathology, cardiology, and ophthalmology to address broader medical imaging needs across multiple specialties. Founded in 1983 and headquartered in Melbourne, Australia, Pro Medicus serves a diverse client base including major healthcare providers and academic institutions primarily in North America, Europe, and Australia. In recent developments, Pro Medicus has accelerated growth through significant long-term contracts, including a record A$330 million 10-year cloud-based enterprise imaging agreement with Trinity Health, covering 93 hospitals across 26 U.S. states, and multiple multimillion-dollar renewals and upgrades with prominent healthcare systems such as NYU Langone Health and University of Florida. The company has also launched new enterprise imaging products targeting additional medical specialties such as cardiology and ophthalmology and is advancing artificial intelligence capabilities within its software portfolio. Pro Medicus made a strategic A$10 million investment in 4DMedical to support respiratory imaging technology and expand its innovation pipeline. Furthermore, it announced a forthcoming product launch in digital pathology in late 2025 and continues to pursue strategic M&A opportunities to enhance its product suite and market position. This expansion aligns with its growth focus on cloud-based digital health data services and increasing geographical presence, particularly in the North American market. Pro Medicus operates with approximately 69 employees and maintains a significant footprint in healthcare informatics, underpinning clinical decision-making through innovative imaging software solutions that promote efficient workflow, improved diagnostic accuracy, and enhanced patient outcomes worldwide. The company remains committed to developing integrated healthcare IT solutions that respond to the evolving demands of medical imaging and digital health ecosystems.
Pro Medicus Limited (PMDIY) Q2 2026 Earnings Call Transcript
Pro Medicus (OTCMKTS:PMCUF) Shares Down 4% – Time to Sell?
Pro Medicus Limited (PMDIY) Shareholder/Analyst Call Transcript
Pro Medicus Limited (PMCUF) Q4 2025 Earnings Call Transcript
Pro Medicus Limited (PMCUF) Q2 2025 Earnings Call Transcript
Pro Medicus Limited (PMCUF) Q4 2024 Earnings Call Transcript
Pro Medicus Limited (PMCUF) Q4 2023 Earnings Call Transcript
Pro Medicus Limited (PMCUF) Q4 2023 Earnings Call Transcript
Pro Medicus Limited (PMCUF) Q2 2023 Earnings Call Transcript
Pro Medicus Limited (PMCUF) CEO Sam Hupert on Q4 2022 Results - Earnings Call Transcript
Pro Medicus Limited (PMCUF) CEO Sam Hupert On Q2 2022 Results - Earnings Call Transcript
Pro Medicus Limited (PMCUF) CEO Sam Hupert on Half Year 2022 Results - Earnings Call Transcript
Pro Medicus' (PMCUF) CEO Sam Hupert on Q4 2021 Results - Earnings Call Transcript
Pro Medicus Limited (PMCUF) CEO Sam Hupert on Q2 2021 Results - Earnings Call Transcript